Prebiopsy neo-adjuvant endocrine therapy for breast cancer to prevent post-surgery trauma-induced growth factor and immune-suppression mediated tumour progression

Eur J Cancer. 1996 Mar;32A(3):396-7. doi: 10.1016/0959-8049(95)00589-7.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / surgery*
  • Disease Progression
  • Growth Substances / adverse effects*
  • Humans
  • Immunosuppression Therapy / adverse effects*
  • Recurrence

Substances

  • Antineoplastic Agents, Hormonal
  • Growth Substances